DexTech Medical AB (XSAT:DEX) Short Percentage of Float


XSAT:DEX DexTech Medical AB XSAT:DEX
32 GF Score
Price kr10.60
! 3 Warning Signs
View Full Analysis

What is DexTech Medical AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XSAT:DEX vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, DexTech Medical AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexTech Medical AB Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Short Percentage of Float falls into.


XSAT:DEX
32GF Score
DexTech Medical AB XSAT:DEX
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
32GF Score

Get the complete analysis for XSAT:DEX

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.60
Price